| Transaction Date | Recipient | Shares | Type | Price | Value |
|---|---|---|---|---|---|
| 20th November 2020 | David F Burgstahler | 4,936,926 | Other acquisition or disposition | $0.00 | |
| 20th November 2020 | Sriram Venkataraman | 4,936,926 | Other acquisition or disposition | $0.00 | |
| 20th November 2020 | Capital Partners Iii Gp, L.P. Avista | 4,936,926 | Other acquisition or disposition | $0.00 | |
| 1st October 2020 | Brian A Markison | 2,277 | Grant/award etc. | $0.00 | |
| 10th August 2020 | Brian A Markison | 1,354 | Grant/award etc. | $0.00 | |
| 21st May 2020 | Fred G Weiss | 17,778 | Payment by withholding | $4.60 | $81,778.80 |
| 21st May 2020 | Gregory L Cowan | 11,112 | Payment by withholding | $4.60 | $51,115.20 |
| 20th May 2020 | Brian A Markison | 249,787 | Grant/award etc. | $0.00 | |
| 20th May 2020 | Fred G Weiss | 38,716 | Grant/award etc. | $0.00 | |
| 20th May 2020 | Gregory L Cowan | 38,716 | Grant/award etc. | $0.00 |
Osmotica Pharmaceuticals Plc
Based on disclosure changes, sentiment, insider trading and news impact we give a rating of 7/10.
Osmotica Pharmaceuticals Plc operates as a biopharmaceutical company. Its products include M-72, Lorzone, ConZip, OB Complete, and Divigel. The company was founded in 1986 and is headquartered in Bridgewater, NJ.
Ticker: OSMT
Sector: Health Technology
Industry: Pharmaceuticals: Major
SEC Central Index Key (CIK): 1739426
Employees: 379
Exchange: NASDAQ
Auditor Opinion:
You must Login to see Language Changes
Disclosure Language changes
You must Login to see analysis
Red Flags
We weren't able to import Fundamental data from the SEC disclosure.
There were no Red Flags found
Fundamentals
We weren't able to import Fundamental data from the SEC disclosure.
